ClinConnect ClinConnect Logo
Search / Trial NCT04988672

OPTIMISER Registry - A Prospective Cohort Study to Describe the OPTIMal Management and Outcomes of PatIents PreSEnting With Acute MyocaRdial Infarction

Launched by LUZERNER KANTONSSPITAL · Jul 25, 2021

Trial Information

Current as of July 26, 2025

Recruiting

Keywords

ClinConnect Summary

The OPTIMISER Registry is a study aimed at understanding how to best manage and improve outcomes for patients who experience a type of heart attack called Acute Myocardial Infarction (AMI). This study will gather important information about patients who are treated with a procedure known as Percutaneous Coronary Intervention (PCI), which helps open blocked arteries. By collecting data from both new and recent heart attack patients, researchers hope to learn more about how different treatments affect recovery and heart health over time.

To participate in this study, individuals must be over 18 years old and either newly diagnosed with AMI or diagnosed within the last five years. It’s important that participants are willing to provide consent for the study. If you join, you can expect to share some health information and be monitored for your recovery progress. This study is currently looking for participants, and it includes all genders, so if you or a family member meet the criteria, you may have the opportunity to contribute to important heart health research.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Subject \>18 years of age
  • Individuals who are newly diagnosed with AMI or have been diagnosed with AMI (STEMI or NSTEMI) within the last 5 years (since 2016).
  • Subjects must be willing to sign a patient informed consent (PIC) OR a patient ́s relative/ proxy are willing to provide PIC or patients have signed the General Consent (GK).
  • Exclusion Criteria:
  • Patient unwilling or unable to provide informed consent
  • Patients with no ACS/AMI (e.g. Takotsubo cardiomyopathy, acute heart failure not related to AMI)

About Luzerner Kantonsspital

Luzerner Kantonsspital (LUKS) is a leading academic hospital located in Lucerne, Switzerland, dedicated to providing high-quality healthcare and advancing medical research. As a prominent clinical trial sponsor, LUKS is committed to fostering innovation in medical treatments and therapies through rigorous clinical studies. The institution emphasizes collaboration with multidisciplinary teams of healthcare professionals, researchers, and academic partners to ensure that its trials adhere to the highest ethical standards and regulatory requirements. With a focus on improving patient outcomes, LUKS leverages its state-of-the-art facilities and expertise to contribute significantly to the advancement of medical science.

Locations

Lucerne, , Switzerland

Patients applied

0 patients applied

Trial Officials

Florim Cuculi, M.D.

Principal Investigator

Luzerner Kantonsspital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials